Zalicus Inc Stock price Nasdaq
Equities
US98887C1053
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | 0.00% |
Financials (USD)
Sales 2014 | 0 | Sales 2015 | 0.7 | Capitalization | 75.33M |
---|---|---|---|---|---|
Net income 2014 | -41M | Net income 2015 | -52M | EV / Sales 2014 | 14,770,294,750 x |
Net cash position 2014 | 14.18M | Net cash position 2015 | 16.68M | EV / Sales 2015 | 83,658,631 x |
P/E ratio 2014 |
-0.83
x | P/E ratio 2015 |
-1.35
x | Employees | - |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+9.16% | 45.97B | |
+53.69% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |
- Stock
- Equities
- Stock EPIRUS Biopharmaceuticals, Inc.
- Stock Zalicus Inc - Nasdaq